ADMET Predictor is an AI/ML platform for drug discovery and chemical risk assessment, enabling rapid and accurate prediction of ADMET properties for compounds.

DDDPlus™ is a leading mechanistic in vitro dissolution simulation software for pharmaceutical formulation and analytical scientists, enabling rapid modeling of drug release.

DILIsym is a quantitative systems toxicology (QST) software platform designed to predict drug-induced liver injury (DILI) hazards and explain underlying mechanisms.

GastroPlus is a leading modeling and simulation software for physiologically-based pharmacokinetics (PBPK) and biopharmaceutics (PBBM), supporting drug development from early research to regulatory filings.

ILDsym is a quantitative systems pharmacology (QSP) modeling software designed to simulate interstitial lung disease (ILD) associated with systemic sclerosis (SSc), accelerating drug development and evaluation.

IPFsym® is a state-of-the-art Quantitative Systems Pharmacology (QSP) software providing a mechanistic, mathematical model for Idiopathic Pulmonary Fibrosis (IPF), designed to accelerate drug development by simulating compound effects on the respiratory system.

MedChem Designer is a free chemical sketching software combining innovative molecule drawing features with fast, accurate ADMET property predictions.

MembranePlus™ is a premier mechanistic modeling software for in vitro permeability and hepatocyte assays, facilitating IVIVE of drug absorption and systemic clearance.

A mathematical modeling and simulation software designed to assess in vitro mitochondrial function and cellular response to drugs or chemicals for pharmaceutical and preclinical research.

MonolixSuite provides a fast, easy-to-use, and powerful set of applications for pharmacometrics analysis, modeling, and simulation in drug development.